The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The Nationwide Cancer Genome Screening Projects for Gastrointestinal Cancer in Japan (SCRUM-Japan GI-SCREEN): Efficient identification of actionable cancer genome alterations in advanced colorectal and non-colorectal gastrointestinal cancer (GI Screen 2013-01-CRC and 2015-01-Non CRC).
 
Kohei Shitara
Honoraria - Chugai Pharma; Takeda
Consulting or Advisory Role - Chugai Pharma; Lilly; Takeda
Research Funding - Bayer (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Dainippon Sumitomo Pharma (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Yakult Pharmaceutical (Inst)
 
Izumi Miki
No Relationships to Disclose
 
Tomohisa Sudo
No Relationships to Disclose
 
Satoshi Fujii
No Relationships to Disclose
 
Takeshi Kuwata
No Relationships to Disclose
 
Wataru Okamoto
No Relationships to Disclose
 
Tadamichi Denda
No Relationships to Disclose
 
Takeshi Kajiwara
No Relationships to Disclose
 
Satoshi Yuki
No Relationships to Disclose
 
Takako Eguchi Nakajima
No Relationships to Disclose
 
Atsuo Takashima
No Relationships to Disclose
 
Kenta Kawasaki
No Relationships to Disclose
 
Takao Tamura
No Relationships to Disclose
 
Taito Esaki
No Relationships to Disclose
 
Takeharu Yamanaka
No Relationships to Disclose
 
Atsushi Ochiai
No Relationships to Disclose
 
Toshihiko Doi
Honoraria - Chugai Pharma; Novartis
Consulting or Advisory Role - Amgen; Lilly; Merck Serono; Otsuka
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst); Zenyaku Kogyo (Inst)
 
Atsushi Ohtsu
No Relationships to Disclose
 
Tomomitsu Hotta
No Relationships to Disclose
 
Takayuki Yoshino
Honoraria - Chugai Pharma; Takeda
Research Funding - Daiichi Sankyo (Inst); Dainippon Sumitomo Pharma (Inst); Lilly (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst); Yakult Pharmaceutical (Inst)